EGFR and squamous cell carcinoma: For metastatic or locally advanced basal or squamous cell carcinoma unamenable to surgery or radiotherapy, targeted therapies—hedgehog pathway inhibitors for basal cell carcinoma (BCC) and epidermal growth factor receptor inhibitors for squamous cell carcinoma—are effective in managing disease progression (28).